CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Chongqing Genrix Biophrmctcl Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Chongqing Genrix Biophrmctcl Co Ltd
Area A, Block 2,
No. 699, Maliu Avenue, Banan District
Phone: +86 2361758666p:+86 2361758666 CHONGQING, CHO  401338  China Ticker: 688443688443
Business Summary
Chongqing Genrix Biopharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, and manufacturing of biopharmaceuticals. The Company's research & development pipeline covers therapeutic areas such as autoimmune diseases, infectious diseases, and oncology. The Company's products include Xeligekimab (GR1501), Silevimig (GR1801), Vecantoxatug (GR2001), Telikibart (GR1802), Velinotamig (GR1803), and others.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2024-----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research

General Information
Number of Employees: 743 (As of 12/31/2024)
Outstanding Shares: 366,680,000 (As of 3/31/2026)
Shareholders: 12,628
Stock Exchange: SHA
Fax Number: +86 2361758011


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 13, 2026